Trial Profile
A Phase I, open label, randomised, single dose, two-way crossover study in healthy volunteers to determine the pharmacokinetics of two transdermal oxymorphone patch formulations to promote pain relief
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Oxymorphone (Primary) ; Naltrexone
- Indications Pain
- Focus Pharmacokinetics
- Acronyms POHO37-13
- Sponsors Phosphagenics
- 11 Aug 2014 Results published in a Phosphagenics media release.
- 11 Aug 2014 Status changed from not yet recruiting to completed according to a Phosphagenics media release.
- 18 Jul 2014 New trial record